An in-depth look to ILYANG PHARMACEUTICAL operating, investing, and financing activities

007570 free cash flow for Q3 24 is -37.92 B KRW. For 2023, 007570 free cash flow was 13.29 B KRW and operating cash flow was 19.38 B KRW.